Detection of the first recurrence in patients with melanoma: Three quarters by the patient, one quarter during outpatient follow-up;Detectie van het eerste recidief bij patiënten met melanoom: Driekwart door de patiënt zelf, één kwart bij poliklinische controle

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 10, 2008, Pages 557-562

  Francken, A B ^a   Thompson, J F ^b   Bastiaannet, E ^c   Hoekstra, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c Integraal Kankercentrum Noord Nederland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CLINICAL FEATURE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MELANOMA; OUTPATIENT; RECURRENT CANCER; RETROSPECTIVE STUDY; SELF EXAMINATION; ADULT; AGED; CANCER STAGING; EVIDENCE BASED MEDICINE; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; PRACTICE GUIDELINE; SKIN TUMOR; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SELF-EXAMINATION; SKIN NEOPLASMS;

EID: 40849150686     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol. 2005;6:608-21.
2. Nieweg OE, Kroon BB. The conundrum of follow-up: should it be abandoned? Surg Oncol Clin N Am. 2006;15:319-30.
3. Vries E de, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107:119-26.
4. Vries E de, Schouten LJ, Visser O, Eggermont AM, Coebergh JW. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Working Group of Regional Cancer Registries. Eur J Cancer. 2003:39:1439-46.
5. Vries E de, Rhee H van der, Coebergh JWW. Trends, oorzaken, aanpak en gevolgen van de huidkankerepidemie in Nederland en Europa. Ned Tijdschr Geneeskd. 2006;150:1108-15.
6. Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol. 2007;14:1924-33.
7. Kim CJ, Reintgen DS, Balch CM. The new melanoma staging system. AJCC Melanoma Staging Committee. Cancer Control. 2002;9:9-15.
8. Richtlijn Melanoom van de huid. Vereniging van Integrale Kanker-centra (VIKC). Kwaliteitsinstituut voor de Gezondheidszorg CBO. Alphen aan den Rijn: Van Zuiden Communications; 2005.
9. Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O'Fallon JR. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA. 1995;274:1703-5.
10. Regan MW, Reid CD, Griffiths RW, Briggs JC. Malignant melanoma, evaluation of clinical follow up by questionnaire survey. Br J Plast Surg. 1985;38:11-4.
11. Baughan CA, Hall VL, Leppard BJ, Perkins PJ. Follow-up in stage I cutaneous malignant melanoma: an audit. Clin Oncol (R Coll Radiol). 1993;5:174-80.
12. Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, et al. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma. Cancer. 1999:86:2252-8.
13. Kersey PA, Iscoe NA, Gapski JA, Osoba D, From L, DeBoer G, et al. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma. Br J Surg. 1985;72:614-7.
14. Mijnhout GS, Teule GJJ, Hoekstra OS, Pijpers R, Borgstein PJ, Meijer S. Follow-up na melanoomverwijdering uitgebreider dan aanbevolen in de consensus, ter geruststelling van de patiënt. Ned Tijdschr Geneeskd. 1999;143:997-1001.
15. Ollila DW. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol. 2006;7:919-24.
16. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. MSLT Group. N Engl J Med. 2006;355:1307-17.